Oral anticoagulant therapy for the prevention of stroke

New England Journal of Medicine

Volumn 345, Issue 20, 2001, Pages 1493-1495

  Powers, William J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; COUMARIN; WARFARIN;

ANTICOAGULANT THERAPY; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; EDITORIAL; HUMAN; PRIORITY JOURNAL; RECURRENCE RISK; SECONDARY PREVENTION; STROKE;

ANTICOAGULANTS; ASPIRIN; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; HUMANS; INTERNATIONAL NORMALIZED RATIO; PLATELET AGGREGATION INHIBITORS; RECURRENCE; WARFARIN;

EID: 0035892037     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200111153452012     Document Type: Editorial

References (23)

1. The Greater Cincinnati/Northern Kentucky Stroke Study: Preliminary first-ever and total incidence rates of stroke among blacks
2. Incidence rates of first-ever ischemic stroke subtypes among blacks: A population-based study
3. Carotid endarterectomy: Where do we draw the line?
4. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke
5. Antithrombotic and thrombolytic therapy for ischemic stroke
6. Pilot study of carotid surgery for acute stroke
7. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke
8. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin
9. Major ongoing stroke trials
10. Comparison of an anticoagulation clinic with usual medical care: Anticoagulation control, patient outcomes, and health care costs
11. Guidelines for the management of spontaneous intracerebral hemorrhage: A statement for health care professionals from a special writing group of the Stroke Council, American Heart Association
12. Anticoagulants for preventing recurrence following ischaemic stroke or transient ischaemic attack
13. Anticoagulant treatment in progressing stroke
14. Anticoagulant therapy in cerebral infarction: Report on cooperative study
15. The Warfarin-Aspirin Symptomatic Intracranial Disease Study
16. Prognosis of patients with symptomatic vertebral or basilar artery stenosis
17. The role of the neurologist in the decline of stroke
18. Antithrombotic drugs for carotid artery dissection
19. Antiphospholipid thrombosis: Clinical course after the first thrombotic event in 70 patients
20. The management of thrombosis in the antiphospholipid-antibody syndrome
21. Atherosclerosis of the thoracic aorta and aortic debris as a marker of poor prognosis: Benefit of oral anticoagulants
22. Baseline frequencies, isotypes, and titers of antiphospholipid antibodies in the Warfarin Aspirin Recurrent Stroke Study/Antiphospholipid Antibody Stroke Study (WARSS/APASS) collaboration: Preliminary results